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Abstract There is currently little data on the longer term
efficacy and safety of balloon kyphoplasty (BKP) in
patients with metastatic vertebral compression fractures
(VCFs). To prospectively assess the long-term efficacy and
safety of BKP in treating thoracic and lumbar spinal
metastatic fractures that result in pain or instability. Sixty-
five patients (37 men, mean age: 66 years) underwent 99
BKP procedures. Patient-related outcomes of pain visual
analogue scale (VAS) and Oswestry Disability Index were
assessed pre- and post-operatively and after 3, 6, 12 and
24 months. Correction of vertebral height and kyphotic
deformity were assessed by radiographic measurements.
Mean pain VAS and Oswestry Disability Index signifi-
cantly improved from pre- to post-treatment (P \ 0.0001),
this improvement being sustained up to 24-month follow
up. A gain in height restoration and a reduction of the post-
operative kyphotic angle were seen post-operatively and at
3 months although these radiographic outcomes returned to
pre-operative levels at 12 months. BKP was associated
with a rate of cement leakage and incidence vertebral
fracture of 12 and 8%, respectively. No symptomatic
cement leaks or serious adverse events were seen during
the 24 months of follow up. BKP is a minimally invasive
procedure that provides immediate and long-term pain
relief and improvement in functional ability in selected
patients with metastatic VCFs. The procedure appears to
have good long-term safety.
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Introduction
Vertebral deformities or vertebral compression fractures
(VCFs) are frequently seen as a consequence of osteolytic or
metastatic disease [13, 15]. VCFs constitute a major health
care problem, not only because of the high incidence of these
lesions but also due to their direct and indirect negative
consequences for patient health-related quality of life and
the costs to the health care system [1, 3, 4, 13, 18, 22].
Balloon kyphoplasty (BKP) is a minimally invasive
procedure that stablises the vertebral fracture and also
provides the opportunity to restore vertebral height and
reduce spinal kyphosis [14, 21]. Kyphosis of the spine may
compromise the biomechanics of the spine, which in turn
predisposes to increased risk of further fractures in the
adjacent vertebrae [10, 19]. A number of reviews have
recently shown BKP to be efficacious, providing rapid pain
relief, reduced need for pain medication, improvement of
functional disability and enhanced health-related quality of
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life [2, 9, 12, 23]. Compared to non-surgical conventional
medical therapy, BKP reduces subsequent adjacent frac-
tures [2, 9, 12, 23] and has a lower risk of cement leakage
when compared to vertebroplasty [9, 12, 23].
Few studies to date have reported on the outcomes of
BKP in the treatment of metastatic lesions of the spine [5,
7, 8, 11, 14, 16, 17, 24]. A recent systematic review
identified that only about 2% of BKP outcome data had
been collected in patients with metastatic VCFs. Further-
more, these data were frequently collected in small number
metastatic lesions in mixed case series where osteoporosis
was the dominant indication with short-term follow up
[23]. Here we report the short-term and longer term effi-
cacy and safety outcomes in a cohort of patients with
metastatic fractures in thoracic and lumbar spine treated
with BKP.
Materials and methods
Patient selection
Between May 2001 and November 2004, 65 patients
underwent BKP. Patients were included in this prospective
series if they have experienced: severe back pain refractory
or danger of further vertebral deformation and osteolytic
lesions of the spine caused by secondary cancer of the
prostate, cervix, rectum, lung, ovaries, pancreas, breast,
skin and gastrointestinal system. All patients pre-opera-
tively underwent a radiograph of the spine and a CT scan of
the fractured vertebral body to evaluate the posterior wall.
Furthermore, all patients underwent an MRI scan of the
spine to detect further asymptomatic lesions (Fig. 1). The
diagnosis was established by the patient history and
radiographic evaluation. The diagnosis of bone metastasis
had been secured on bone aspirate and trephine biopsy.
BKP was not performed in case of a severe spinal stenosis
with infiltration of the posterior wall or if the patient had
any neurological deficit according to the vertebra which
should be treated. All surgical procedures were done with
informed consent from the patients.
Implants and surgical technique
BKP was performed under general anaesthesia using the
KyphX System (Kyphon Inc., Sunnyvale, California).
The surgical technique for the procedure has been descri-
bed by Lieberman et al. [14]. A bilateral approach was
chosen to insert working cannulas into the posterior part of
the vertebral body. Biplanar fluoroscopy was used to insert
the tools and control the procedure. With reaming tools,
two working channels were created and the KyphX
Xpander balloons were inserted. The KyphX Xpander
balloons are available in lengths of 10, 15 and 20 mm. The
KyphX Xpander balloons should ideally be centered
between the endplates in the anterior two-thirds of the
vertebral body. Their placement can be controlled by two
radiopaque markers at the ends of the balloon. Once
inserted, the KyphX Xpander balloons were inflated using
visual, volume and pressure control to create a cavity.
Inflation was stopped when one of the endpoints of infla-
tion was reached: the pressure raised over 400 psi, the
KyphX Xpander balloon contacted the cortical wall of the
vertebra or the maximal inflation volume of the balloon
was reached. The balloons were then deflated and removed.
The mean balloon inflation volume was 4.1 ml (range 1.3–
5.5 ml). The KyphX Bone Filler Device, which was filled
before with 1.5 ml of polymethylmethacrylate (PMMA),
was then advanced through the working cannula towards
the anterior part of the cavity and cement was slowly
extruded by a stainless steel stylet, acting as a plunger.
When the amount of cement from 1 KyphX Bone Filler
Device was delivered in the cavity, the first was removed
and the next KyphX Bone Filler Device was advanced
through the working cannula. This step was repeated till a
complete fill of the cavity was obtained. The same proce-
dure was repeated through the other working cannula at the
contra-lateral pedicle. Filling of the cavity with highly
viscous PMMA was performed under continuous fluoro-
scopic control.
All patients were treated with the same post-operative
protocol and were mobilised one day post-operatively.
Radiographic controls were performed 1–3 days after
operation (Fig. 1). Analgesia was adapted to the severity of
the back pain: no opiate analgesia was necessary post-
operatively. All patients received oncologic treatment
(radiation therapy and/or chemotherapy) 2–4 weeks post-
intervention.
Outcomes
Outcomes were assessed prior to surgery, post-operatively
and at 3, 6, 12 and 24 months.
Patient-related measures
Back pain was assessed using with a ten-point visual
analogue scale (VAS) where a score of zero indicated ‘no
pain’ and a score of 10 indicated ‘severe pain’ (10).
Functional capacity was assessed using the oswestry dis-
ability instrument (ODI) [6].
Radiographic parameters
Plain digital radiographs were performed before and 3 days
after surgery, at 3, 6, 12 and 24 months follow-up.
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Additionally, radiographic evaluation including CT-scans
with sagittal 2-D reconstruction as well as MRI was per-
formed before surgery. The CT scan was performed in a
multi detector spiral CT 16 row (Light Speed Pro 16, GE,
Milwaukee, Wisc., USA). The slice thickness was 2.5 mm
with a bone algorithm. MRI (Signa 1.5 T, GE, Milwaukee,
Wisc., USA) scanning included T1 and T2 sequences;
0.2 mg/kg body weight paramagnetic contrast agent
(Magnevist, Schering, Berlin, Germany) was used.
Loss of vertebral body height and degree of kyphosis
were measured in lateral radiographs by calliper in the
digital system. The anterior and mid-vertebral heights were
defined as the distance between the upper and lower
endplates at the anterior vertebral wall and in the centre of
the vertebra, respectively. The normal heights for the
anterior vertebral wall and mid-vertebral region were
considered as the sum of the measurement of the corre-
sponding heights of the adjacent superior and inferior
nearest non-fractured vertebrae divided by two. Two
independent assessors evaluated radiometric outcomes.
Adverse events
All adverse events, including cement leakages were col-
lected. Cement leaks were confirmed by intra-operative
fluoroscopy and post-operative radiograph. New fractures
Fig. 1 Pre-operatively and radiograph pre-, post-operatively, and
2 years post-operatively of a 82-year-old patient with a metastatic
ovarial carcinoma treated with Balloon-kyphoplasty in level T 11 and
L2. a–c MRI preoperatively. d–e Radiograph preoperatively. f–g
Radiograph postoperatively. h–i Radiograph 1 year. j–k Radiograph
2 years
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were assessed in previously unfractured and pre-fractured
vertebrae.
Statistical analysis
All outcomes were reported descriptively at all assessment
points. To maximise statistical efficiency, repeated mea-
sures analysis of variance (ANOVA) was first used to
assess within person differences across the six outcome
time points [24]. Where the ANOVA model showed sta-
tistical significance (P B 0.05), within group t tests were
used to compare differences in means across pairs of time
points. Differences are expressed as means and 95% con-
fidence intervals (95% CI). All analyses were conducted
using Stata v.8.0 (Stata Corp, College Station, Texas).
Results
A total of 65 consecutive patients meeting the inclusion
criteria were included and underwent a total of 99 BKP
procedures (see Table 1). Two-year follow up was avail-
able on 41 patients. Thirteen patients died before 1-year
follow up and another nine patients died from between 12
and 24 months. Two patients had a cardiac arrest all others
deaths were cancer related. None of the deaths were pro-
cedure related.
Patient-related outcomes
Balloon Kyphoplasty treated patients exhibited a marked
improvement in mean VAS pain (33 vs. 83 mm) and mean
ODI scores (38 vs. 81) post-operatively (both P \ 0.0001)
which continued to improve to 3-months. There was some
evidence of a small but not clinically important deteriora-
tion of VAS and ODI score from in period from 6 to
24 months follow up (Table 2, Figs. 2, 3).
Radiographic outcomes
Post-operatively, midline and anterior vertebral body
height was significantly increased (P \ 0.0001) and this
change was maintained at 3 months follow up. Over the
period of 6–24 months, midline and anterior vertebral
height gradually decreased to a pre-operative level
(Table 3, Fig. 4, 5). A similar pattern of change was
seen in kyphotic angle, i.e. a significant reduction in
Table 1 Pre-operative patient characteristics and operative details
Total patients N = 65 N (%) or mean (SD)
Sex, male 37 (57%)
Age, years 66 (9)
No. of vertebral levels operated on
One level 37 (59%)
Two levels 23 (25%)
Three levels 4 (6%)
Four levels 1 (2%)
Pre-operative pain VAS 83 (15)
Pre-operative ODI 81 (8)
Table 2 Pain VAS and ODI scores—preoperative and at follow up
Pain VAS ODI
N patients Mean (SD) N patients Mean (SD)
Pre-operative 65 83 (15) 65 81 (8)
Post-operative 65 33 (9)*** 65 39 (7)***
3-months 63 29 (9)*** 63 33 (6)***
6-months 58 29 (10)*** 59 32 (7)***
12-months 52 31 (10)*** 52 32 (7)***
24-months 41 32 (10)*** 41 35 (6)***
*** P \ 0.0001 compared to pre-operative;  P \ 0.0001 com-
pared to post-operative;  P \ 0.001 compared to post-operative
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Fig. 2 Pattern of change in pain VAS scores. Time 0: pre-operative;
time 3–4 days: post-operative
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Fig. 3 Pattern of change in ODI scores. Time 0: pre-operative; time
3–4 days: post-operative
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post-operative kyphotic angle, which returned to a pre-
operative level over the 24-month period (Table 3, Fig. 6).
Adverse events
No neurologic, embolic or cardiovascular complications
were observed in any patient during or the 24 months after
BKP. PMMA cement leakages were observed in 12 out of
99 treated vertebral bodies (12.1%). Five patients (8%)
experienced an adjacent incident fracture, three of which
occurred in the first 6 months following the procedure. In
two of these patients a BKP was performed again while
three patients were treated conservatively.
Operative details
The procedure took on average 32 min for each level, the
mean amount of cement application being 5.3 ml (range
2.5–8.5) per vertebra. All patients were discharged from
the hospital between the second and fourth day post-
procedure.
Discussion
Patients with osteolytic lesions due to metastatic disease
are subject to significant mortality and morbidity [13, 15].
Given improved survival with contemporary oncologic
treatment, effective management of pain, disability and
loss of health-related quality of life is becoming increa-
singly important. BKP is a minimally invasive procedure
Table 3 Vertebral height and kyphotic angle—pre-operative and at follow up
Anterior vertebral height (mm) Midline vertebral height (mm) Kyphotic angle ()
N Mean (SD) N Mean (SD) N Mean (SD)
Pre-operative 99 23.7 (2.4) 98 24.5 (1.8) 99 12.0 (2.3)
Post-operative 99 24.2 (2.4)*** 98 24.8 (1.9)** 98 11.1 (2.4)***
3-months 94 24.2 (2.5)*** NS 92 24.8 (1.9)* 94 11.5 (2.4)**
6-months 83 23.9 (2.5)** NS 81 24.6 (1.9)* 83 11.8 (2.4)*
12-months 76 23.6 (2.4)* 76 24.5 (1.9)** 76 11.8 (2.4)*
24-months 57 23.7 (2.3)* 60 24.5 (1.9) NS 53 12.0 (3.3) NS
*** P \ 0.0001 compared to pre-operative; ** P \ 0.001 compared to pre-operative; * P \ 0.05 compared to pre-operative;  P \ 0.0001
compared to post-operative;  P \ 0.001 compared to post-operative;  P \ 0.05 compared to post-operative; NS P [ 0.05 not statistically
significant
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Fig. 4 Pattern of change in anterior vertebral height. Time 0: pre-
operative; time 3–4 days: post-operative
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Fig. 5 Pattern of change in midline vertebral height. Time 0: pre-
operative; time 3-days: post-operative
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Fig. 6 Pattern of change in kyphotic angle. Time 0: pre-operative;
time 3–4 days: post-operative
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that stabilises the vertebral fracture, that is known reduce
the intensity of pain and enhance patient function and
health-related quality of life of patients with painful
osteoporotic VCFs [2, 12, 23]. Few studies have reported
on the outcomes of BKP in the treatment of metastatic
lesions of the spine.
This prospective study shows BKP to provide pain relief
and improve the functional capacity of patients with
painful or unstable metastatic VCFs up to 24 months
following intervention. BKP was found to be a safe pro-
cedure, no patient experiencing a symptomatic cement
leakage or other serious adverse event.
Our clinical efficacy findings are consistent with those
of previous studies of BKP in these patients with malignant
lesions. Dudeney et al. [5] reported on the treatment of
vertebral fractures in multiple myeloma lesions. They
performed 55 BKP procedures in 18 patients. In concor-
dance with our results, significant improvement were seen
in average pain score (VAS) for BKP from pre- to post-
treatment, as well as for the oswestry disability index
(P \ 0.05). Furthermore significant improvement in
health-related quality of life (Short Form-36) scores was
seen for the domains bodily pain, physical function, vita-
lity, and social functioning. At 1-year follow-up, both pain
VAS and Oswestry Disability Index increased slightly.
This increase was thought by the authors to reflect disease
progression. Masala et al. [16] treated 33 patients (2
patients with aggressive hemangioma, 8 patients with
myeloma, and 23 patients with metastases) suffering from
severe motion pain in the back with BKP and vertebro-
plasty. The two interventions had an equivalent impact on
pain relief up to 6-month post-procedures.
A specific advantage of BKP is that it makes cement
augmentation safer [2, 9, 12, 23]. In our study PMMA
cement leaks were seen in 12% of treated vertebrae. This
figure is comparable with the range of leakage reported by
BKP studies in malignant VCFs, i.e. 0–21.8% [23]. In
contrast, systematic reviews of vertebroplasty series have
reported an overall cement leak rate of some 40%, ranging
from of 2 to 67% [12, 23]. Fourney et al. [7] reported a
direct comparison on the treatment of tumorous lesions
with vertebroplasty and kyphoplasty in 56 patients under-
going 65 vertebroplasties and 32 balloon kyphoplasties.
Leakage was observed in 9% of vertebroplasties and 0% of
balloon kyphoplasties.
In accord with previous studies in metastatic lesions,
BKP was associated with a restoration in vertebral height
and kyphotic angle post-operatively and in the 3-month
period following procedure [5, 7, 8, 11, 16, 20, 24]. These
radiographic outcomes were seen to return to pre-operative
levels at 12 months and beyond. However, unlike pain
relief and enhanced function, height restoration and
kyphotic correction are not the first priority in this
population. That improvements in deformity were not
sustained is most plausibly related to the natural history of
the disease, i.e. a gradual continued increase of vertebral
deformity over the disease course. Although BKP
may simply serve to delay the deformity process for a
3–6-month period, importantly pain relief and improve-
ments in function were sustained to 24 months.
Further, all patients in this study received radiation
therapy and/or chemotherapy, we believe it unlikely that
these therapies would have substantially contributed to the
improvements in outcomes seen in this study.
Conclusions
Balloon kyphoplasty is a minimally invasive procedure that
provides immediate and long-term pain relief and
improvement in functional ability in selected patients with
metastatic VCFs. The procedure appears to have good
long-term safety.
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